| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |